Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

The statewide network is designed to overcome manufacturing bottlenecks that have delayed or stalled development and approval of regenerative medicines. “These awards are a critical first step in ...

Title 17 California Code of Regulations Section 100080(f) designates all human pluripotent stem cell lines derived in accordance with the CIRM regulations as “acceptably derived.” These cell lines may ...

CIRM’s core programs focus on critical areas that drive the development and commercialization of regenerative medicine treatments. Spanning education, research, and funding opportunities, these ...

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

Anne-Marrie Duliege, MD, is a Senior Executive and Chief Medical Officer with 30 years of experience guiding biopharmaceutical companies through development and commercial stages. Dr. Duliege is ...

超过二十种人类遗传疾病是由必需基因内由三个核苷酸重复（例如 CAG、CTG、CGG 和 GAA）组成的简单 DNA 序列的扩展引起的。这些重复可能发生在编码蛋白质的基因区域内，通常会导致蛋白质具有 ...

David Higgins, PhD, earned his PhD in molecular biology and genetics from the University of Rochester in New York, followed by a postdoctoral fellowship at the National Cancer Institute before moving ...

San Francisco, CA – California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM) today approved $150 million in new funding to help move promising stem cell-based therapies ...

本提案的总体目标是开发新方法和技术，以提高我们设计造血干细胞的能力。这些是存在于…中的成体干细胞。 继续阅读造血干细胞中的位点特异性基因编辑作为抗 HIV 疗法 干细胞基因组学卓越 ...